274 related articles for article (PubMed ID: 27515251)
1. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.
Attarbaschi A; Carraro E; Abla O; Barzilai-Birenboim S; Bomken S; Brugieres L; Bubanska E; Burkhardt B; Chiang AK; Csoka M; Fedorova A; Jazbec J; Kabickova E; Krenova Z; Lazic J; Loeffen J; Mann G; Niggli F; Miakova N; Osumi T; Ronceray L; Uyttebroeck A; Williams D; Woessmann W; Wrobel G; Pillon M;
Haematologica; 2016 Dec; 101(12):1581-1591. PubMed ID: 27515251
[TBL] [Abstract][Full Text] [Related]
2. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E; Oschlies I; Zimmermann M; Moser O; Graf N; Suttorp M; Greiner J; Reiter A;
Br J Haematol; 2008 Nov; 143(3):387-94. PubMed ID: 18729852
[TBL] [Abstract][Full Text] [Related]
3. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
4. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A; Carraro E; Ronceray L; Andrés M; Barzilai-Birenboim S; Bomken S; Brugières L; Burkhardt B; Ceppi F; Chiang AKS; Csoka M; Fedorova A; Jazbec J; Kabickova E; Loeffen J; Mellgren K; Miakova N; Moser O; Osumi T; Pourtsidis A; Rigaud C; Uyttebroeck A; Woessmann W; Pillon M;
Leukemia; 2021 Feb; 35(2):534-549. PubMed ID: 32393843
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols.
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Pediatr Blood Cancer; 2008 Mar; 50(3):633-5. PubMed ID: 17366531
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
8. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.
Bienemann K; Burkhardt B; Modlich S; Meyer U; Möricke A; Bienemann K; Mauz-Körholz C; Escherich G; Zimmermann M; Körholz D; Janka-Schaub G; Schrappe M; Reiter A; Borkhardt A
Br J Haematol; 2011 Nov; 155(4):468-76. PubMed ID: 21923652
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.
Thorer H; Zimmermann M; Makarova O; Oschlies I; Klapper W; Lang P; von Stackelberg A; Fleischhack G; Worch J; Juergens H; Woessmann W; Reiter A; Burkhardt B
Haematologica; 2014 Nov; 99(11):e238-41. PubMed ID: 25107886
[No Abstract] [Full Text] [Related]
10. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G
Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550
[TBL] [Abstract][Full Text] [Related]
11. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
12. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia.
Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D
Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
14. Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Schütte P; Möricke A; Zimmermann M; Bleckmann K; Reismüller B; Attarbaschi A; Mann G; Bodmer N; Niggli F; Schrappe M; Stanulla M; Kratz CP
Eur J Med Genet; 2016 Mar; 59(3):143-51. PubMed ID: 26732628
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
16. The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Pichler H; Reismüller B; Steiner M; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Panzer-Grümayer R; Haas OA; Attarbaschi A; Mann G;
Br J Haematol; 2013 May; 161(4):556-65. PubMed ID: 23480776
[TBL] [Abstract][Full Text] [Related]
17. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
18. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
[TBL] [Abstract][Full Text] [Related]
19. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.
Kobayashi R; Mitsui T; Fujita N; Osumi T; Aoki T; Aoki K; Suzuki R; Fukuda T; Miyamoto T; Kato K; Nakamae H; Goto H; Eto T; Inoue M; Mori T; Terui K; Onizuka M; Koh K; Koga Y; Ichinohe T; Sawada A; Atsuta Y; Suzumiya J
Int J Hematol; 2017 Mar; 105(3):369-376. PubMed ID: 27787746
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
